India Soft Tissue Repair Market Size Likely to Grow at a CAGR of 7.8% By 2035

The market size of the global soft tissue repair is estimated to be USD 485.6 billion in 2025, and it is estimated that such a market size will rise to USD 520.3 billion in 2026, and to around USD 1,020.7 billion in 2035, at an annual CAGR of 7.8% between the years 2026 and 2035.

India soft tissue repair Market Revenue and Trends

The India soft tissue repair market is projected to witness strong and sustained growth during 2026–2035, driven by the rising burden of trauma injuries, sports-related injuries, hernia cases, and reconstructive surgeries. Sutures, surgical mesh, tissue patches, fixation devices and biologics are soft tissue repair products that are being increasingly used in orthopedic, general surgery, plastic surgery, and cardiovascular surgery in both the public and private healthcare systems.

The growth in revenue can also be provided by the growing healthcare infrastructure in India, the rising acceptance of the advanced surgery methods, and the growing popularity of the minimally invasive surgeries. With the increased volume of surgery in both tier I and tier II cities, the demand for the durable, biocompatible and economical solutions of soft tissue repair is likely to pick up.

What are the Factors That Have a Significant Contribution to the Growth of the India soft tissue repair market?

The growth of the India soft tissue repair market is primarily driven by the increasing demand for surgical interventions across both public and private healthcare facilities. Rising cases of road accidents, occupational injuries, and age-related musculoskeletal conditions are increasing the need for effective soft tissue reconstruction and reinforcement solutions.

India is witnessing a steady rise in minimally invasive and laparoscopic procedures, particularly for hernia repair, orthopedic reconstruction, and sports injury management. These procedures require specialized sutures, meshes, and fixation devices, thereby supporting consistent demand for soft tissue repair products. The growing adoption of advanced surgical practices in tier I and tier II cities is further strengthening market growth.

The technological improvements are becoming overly instrumental in enhancing the clinical outcomes and surgeon preference. The use of absorbable nets, antibacterial sutures, biologic grafts and collagen-based material repair mechanisms has increased the efficiency of healing besides minimizing the post-operative complications and chances of infection. These are the innovations that are speeding up the substitution of the traditional products with the advanced soft tissue repair solutions.

Segment Insight

By Product

The India soft tissue repair market shares are fixed products with the largest market share as of 2025 because of the extensive use of the products in orthopedic, sports medicine, and trauma surgeries that demand high and stable tissue fixation. These products are essential in ensuring tendon and ligament security, preserving an anatomical appearance and providing a faster healing process, and the continuous advancement in bio-absorbable material, knotless structures and less invasive fixation designs has greatly enhanced the effectiveness and efficiency of the surgical procedure and patient clinical outcomes (such fixation devices are the solution of choice in high-volume surgeries where appearance is crucial and where cost-effectiveness is paramount).

By Application

Orthopedic surgery accounted for the dominant share of the India soft tissue repair applications market as of 2025 because of the high incidence of ligament, tendon, and muscle injuries associated with road accidents, sports participation, and age-related degenerative disorders. Soft tissue repair solutions are essential for restoring mobility and joint stability in orthopedic procedures, and advancements in arthroscopic techniques and minimally invasive surgeries have further increased the reliance on specialized repair products (widely regarded by surgeons as effective solutions for improving recovery time and long-term functional outcomes).

By End Uses

Hospitals and clinics held the biggest share of the India soft tissue repair end-use market as of 2025 due to their ability to manage high surgical volumes, availability of skilled orthopedic and general surgeons, and access to advanced operating room infrastructure. These facilities play a central role in performing complex soft tissue repair procedures and providing comprehensive post-operative care, while growing patient trust, insurance coverage, and preference for hospital-based treatment continue to strengthen their market dominance (considered the most reliable settings for safe and effective surgical intervention).

Report Scope

Recent Developments

• In June 2025, OSSIO launched its new OSSIOfiber 2.5mm small suture anchors, a fully bio-integrative, metal-free fixation implant aimed at improving soft tissue surgical outcomes across numerous joint and tendon repairs.

List of the prominent players in the India Soft Tissue Repair Market:

• Johnson & Johnson (Ethicon)

• Medtronic

• Smith & Nephew

• Stryker

• Zimmer Biomet

• Arthrex

• Baxter International

• Becton

• Dickinson and Company (BD)

• Integra LifeSciences

• Boston Scientific

• Organogenesis

• LifeCell (AbbVie)

• MIMEDX Group

• Cook Medical

• CryoLife

• LifeNet Health

• TELA Bio

• Aesculap (B. Braun)

• ConMed

• Acumed

• Others

The India Soft Tissue Repair Market is segmented as follows:

By Products

• Fixation

  • Suture

  • Suture Anchors

  • Others

• Tissue Patch/Match

  • Biological

  • Synthetic

By Applications

• Orthopedic Surgery

• Breast Reconstruction

• Hernia Repair

• Skin Repair

• Vaginal Sling Repair

• Cardiovascular Surgery

• Others

By End Uses     

• Hospitals and Clinics

• Research and Academic Institutes

• Others